Data Visionaries at WuXi NextCODE rely on sequence data to:
- Populate the world's largest collection of human genome sequences
- Pinpoint genetic differences and mutations across massive data sets
- Cost-effectively and efficiently advance life-changing medical treatments
Every year, 1.6 million people are diagnosed with cancer. One in three adults suffer from multiple chronic conditions. And there are approximately 7,000 rare diseases that affect 300 million people globally. The answer to preventing and treating disease lies in human genes—and global genomic information company WuXi NextCODE is at the forefront of data-driven precision medicine.
According to Dr. Gudbjartsson, PhD, WuXi NextCODE CIO, "If we compare two people's DNA, we would see 5 million differences. The challenge is to take a dataset of 5 million and figure out the differences or mutations that are important—which ones are the causes of rare diseases, which ones are the causes of cancer, and how to treat patients."
Together with his team at WuXi NextCODE, Dr. Gudbjartsson has embraced a data-driven approach to make individualized medical treatment more accessible, affordable, and scalable for people all over the world. With the largest database of human genome sequences in the world, this data-driven organization refers to its platform as "the internet of DNA."
A database designed with human DNA at its heart
At the heart of the WuXi NextCODE platform is the genomic relational database—the only data architecture designed to optimize the use of massive amounts of genomic data.
According to Rob Brainin, CEO of WuXi NextCODE, "It was only 15 years ago that the first whole human genome was sequenced. It took two decades and cost almost $3 billion to do. The cost has come down radically to under a $1,000 and a few days, but that's generated a tsunami of data."
The WuXi NextCode platform's architecture is designed to support not only this tsunami of data, but also genomics efforts on four continents. It is the global standard for organizing, mining, and sharing large-sequence datasets that are transforming medical care.
"We are really relying on NetApp in the cloud," said Dr. Gudbjartsson. "The benchmark for analyzing genomic data is accessing it from data from 100,000 individuals. We always had timeouts or file failures. But when we tested this using the NetApp Cloud Volumes Service, it actually finished in less than an hour. That was a great breakthrough for us."
NetApp's technology has been essential to WuXi NextCODE's cloud transformation. By leveraging NetApp® Cloud Data Services, WuXi NextCODE's genome platform makes it possible to integrate data on the fly to deliver unprecedented computational efficiency.
"NetApp's been a key technology partner throughout our cloud journey," said Andy Cosgrove, VP, Strategic Alliances & Channel Partners at WuXi NextCODE. "Our customers are demanding performance and efficiency in the cloud. NetApp's there with WuXi NextCODE to deliver."
Dr. Gudbjartsson continues: "Being able to gather these big data sets and mine them efficiently is very important for data-driven personalized medicine. Helping you to understand diseases better, to develop new drugs. We believe we are giving our customers the ultimate experience."
With offices in Cambridge, Shanghai, and Reykjavik, WuXi NextCODE is a genomic information company and global platform that uses sequence data to improve health for people around the world.< Back to Data Visionary Home